The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1309
ISSUE1309
April 6, 2009
Valproic Acid Delayed Release (Stavzor)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Valproic Acid Delayed Release (Stavzor)
April 6, 2009 (Issue: 1309)
The FDA has approved a delayed-release capsule formulation of valproic acid (VPA; Stavzor - Noven Therapeutics) for all of the indications for which divalproex sodium (Depakote, and others; Depakote ER) is approved: monotherapy and adjunctive therapy...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.